A mother writes a letter to her daughter who should be turning 16-years old. Instead, she lost her life to childhood cancer
We are excited to help support the research for a pediatric cancer clinical trial targeting relapsed neuroblastoma and newly diagnosed DIPG.
This family left their home country of Armenia to receive cancer care from Levine Children’s new rare pediatric cancer program in Charlotte.
Mason, diagnosed with neuroblastoma in 2019, will continue his care under Dr. Sholler and her Isabella Santos Foundation Rare & Solid Tumor Program team.
Walt was diagnosed with stage IV high-risk neuroblastoma on July 24th, 2019. Walt and his parents left their tribe to get the best cancer care possible.